This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Framingham Study

Tavia Gordon; William B. Kannel, MD, MPH; William P. Castelli, MD; Thomas R. Dawber, MD

Arch Intern Med. 1981;141(9):1128-1131.

Abstract
• Based on six years of follow-up evaluations of the Framingham, Mass, men and women aged 49 to 82 years, it was found that a low-density lipoprotein (LDL) cholesterol concentration was associated with a low incidence of coronary heart disease (CHD) risk but with a statistically significant excess of stroke incidence in women and of deaths from non-CHD causes in both sexes. There was no suggestion that an elevated HDL cholesterol level was associated with an excess incidence of any of the cardiovascular end points considered or of death. An inverse relation of high-density lipoprotein (HDL) cholesterol level with CHD and its major consequences, CHD death and congestive heart failure, was observed. Triglyceride determinations seem to add little information respecting cardiovascular risk to that elicited from HDL and LDL cholesterol and other known cardiovascular risk factors. While the relation of HDL and LDL cholesterol with CHD is paralleled by findings from a variety of sources, the inverse relation of LDL cholesterol with stroke in women and with death from non-CHD causes requires additional confirmation and exploration.

(Arch Intern Med 1981;141:1128-1131)

Author Affiliations
From the National Heart, Lung, and Blood Institute, Bethesda, Md (Mr Gordon and Dr Castelli); Framingham Heart Study, Framingham, Mass (Dr Castelli); Section of Preventive Medicine and Epidemiology, Boston University School of Medicine (Drs Kannel and Dawber); and the Evans Research Foundation, Boston (Drs Kannel and Dawber). Mr Gordon is retired and is a consultant biometrician.

Footnotes
Accepted for publication July 14, 1980.

Reprint requests to Framingham Heart Study, 18 Lincoln St, Framingham, MA 01701 (Dr Castelli).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population: The Hisayama Study
Imamura et al.
Stroke 2009;40:382-388.
ABSTRACT | FULL TEXT  

Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
Freiberg et al.
JAMA 2008;300:2142-2152.
ABSTRACT | FULL TEXT  

High Plasma Level of Remnant-Like Particles Cholesterol in Familial Combined Hyperlipidemia
de Graaf et al.
J. Clin. Endocrinol. Metab. 2007;92:1269-1275.
ABSTRACT | FULL TEXT  

Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment
Pedersen et al.
Diabetes and Vascular Disease Research 2006;3:S1-S12.
ABSTRACT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Circulation 2006;113:e873-e923.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Stroke 2006;37:1583-1633.
ABSTRACT | FULL TEXT  

Decreased High-Density Lipoprotein (HDL) Particle Size, Pre{beta}-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness
Watanabe et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:897-902.
ABSTRACT | FULL TEXT  

Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy
Christ et al.
Eur Heart J 2006;27:691-699.
ABSTRACT | FULL TEXT  

Quantification of Lipoprotein Subclasses by Proton Nuclear Magnetic Resonance-Based Partial Least-Squares Regression Models
Petersen et al.
Clin. Chem. 2005;51:1457-1461.
ABSTRACT | FULL TEXT  

High Density Lipoprotein Cholesterol and the Risk of Stroke in Elderly Men: The Honolulu Heart Program
Curb et al.
Am J Epidemiol 2004;160:150-157.
ABSTRACT | FULL TEXT  

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome
Coughlin et al.
Eur Heart J 2004;25:735-741.
ABSTRACT | FULL TEXT  

Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype
Twickler et al.
Circulation 2004;109:1918-1925.
FULL TEXT  

High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study
Soyama et al.
Stroke 2003;34:863-868.
ABSTRACT | FULL TEXT  

Dietary Fats Differentially Modulate the Expression of Lecithin:Cholesterol Acyltransferase, Apoprotein-A1 and Scavenger Receptor B1 in Rats
Hatahet et al.
J. Nutr. 2003;133:689-694.
ABSTRACT | FULL TEXT  

Plasma Lipid Profile and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
Shahar et al.
Stroke 2003;34:623-631.
ABSTRACT | FULL TEXT  

An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients
Koro et al.
Arch Gen Psychiatry 2002;59:1021-1026.
ABSTRACT | FULL TEXT  

Differential Reactivity of Two Homogeneous LDL-Cholesterol Methods to LDL and VLDL Subfractions, as Demonstrated by Ultracentrifugation and HPLC
Usui et al.
Clin. Chem. 2002;48:1946-1954.
ABSTRACT | FULL TEXT  

Prolonged Stimulation of the Adrenals by Corticotropin Suppresses Hepatic Low-Density Lipoprotein and High-Density Lipoprotein Receptors and Increases Plasma Cholesterol
Galman et al.
Endocrinology 2002;143:1809-1816.
ABSTRACT | FULL TEXT  

Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe
Bots et al.
J. Epidemiol. Community Health 2002;56:i19-24.
ABSTRACT | FULL TEXT  

Blood Lipids and First-Ever Ischemic Stroke/Transient Ischemic Attack in the Bezafibrate Infarction Prevention (BIP) Registry: High Triglycerides Constitute an Independent Risk Factor
Tanne et al.
Circulation 2001;104:2892-2897.
ABSTRACT | FULL TEXT  

Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I
Shah et al.
Circulation 2001;104:2376-2383.
FULL TEXT  

Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?
Rizos and Mikhailidis
Cardiovasc Res 2001;52:199-207.
ABSTRACT | FULL TEXT  

Determinants of Peripheral Arterial Disease in the Elderly: The Rotterdam Study
Meijer et al.
Arch Intern Med 2000;160:2934-2938.
ABSTRACT | FULL TEXT  

Prevalence and Phenotypic Distribution of Dyslipidemia in Type 1 Diabetes Mellitus: Effect of Glycemic Control
Perez et al.
Arch Intern Med 2000;160:2756-2762.
ABSTRACT | FULL TEXT  

Pravastatin, Blood Pressure, and Stroke Response
Wilkinson et al.
Hypertension 2000;e2: -e1.
FULL TEXT  

Analytical and Clinical Evaluation of Two Homogeneous Assays for LDL-Cholesterol in Hyperlipidemic Patients
Esteban-Salan et al.
Clin. Chem. 2000;46:1121-1131.
ABSTRACT | FULL TEXT  

HDL-Cholesterol, Total Cholesterol, and the Risk of Stroke in Middle-Aged British Men
Wannamethee et al.
Stroke 2000;31:1882-1888.
ABSTRACT | FULL TEXT  

Lipoprotein (a) and stroke
Milionis et al.
J. Clin. Pathol. 2000;53:487-496.
ABSTRACT | FULL TEXT  

Vegetable Oils High in Phytosterols Make Erythrocytes Less Deformable and Shorten the Life Span of Stroke-Prone Spontaneously Hypertensive Rats
Ratnayake et al.
J. Nutr. 2000;130:1166-1178.
ABSTRACT | FULL TEXT  

LDL Cholesterol as a Strong Predictor of Coronary Heart Disease in Diabetic Individuals With Insulin Resistance and Low LDL : The Strong Heart Study
Howard et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:830-835.
ABSTRACT | FULL TEXT  

Discontinuation of Growth Hormone (GH) Treatment: Metabolic Effects in GH-Deficient and GH-Sufficient Adolescent Patients Compared with Control Subjects
J. Clin. Endocrinol. Metab. 1999;84:4516-4524.
ABSTRACT | FULL TEXT  

Different Risk Factors for Different Stroke Subtypes : Association of Blood Pressure, Cholesterol, and Antioxidants
Leppala et al.
Stroke 1999;30:2535-2540.
ABSTRACT | FULL TEXT  

Light-to-Moderate Alcohol Consumption and the Risk of Stroke among U.S. Male Physicians
Berger et al.
NEJM 1999;341:1557-1564.
ABSTRACT | FULL TEXT  

Alcohol Consumption and Stroke Incidence in Male Smokers
Leppala et al.
Circulation 1999;100:1209-1214.
ABSTRACT | FULL TEXT  

Oxidation of LDL in baboons is increased by alcohol and attenuated by polyenylphosphatidylcholine
Navder et al.
J. Lipid Res. 1999;40:983-987.
ABSTRACT | FULL TEXT  

Forecasting Patient Outcomes in the Management of Hyperlipidemia
Brier et al.
Arch Intern Med 1999;159:569-575.
ABSTRACT | FULL TEXT  

Comparison of Cytochrome P-450-Dependent Metabolism and Drug Interactions of the 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Lovastatin and Pravastatin in the Liver
Jacobsen et al.
Drug Metab. Dispos. 1999;27:173-179.
ABSTRACT | FULL TEXT  

Reduction of Stroke Incidence After Myocardial Infarction With Pravastatin : The Cholesterol and Recurrent Events (CARE) Study
Plehn et al.
Circulation 1999;99:216-223.
ABSTRACT | FULL TEXT  

The Effect of a Pure Antiandrogen Receptor Blocker, Flutamide, on the Lipid Profile in the Polycystic Ovary Syndrome
Diamanti-Kandarakis et al.
J. Clin. Endocrinol. Metab. 1998;83:2699-2705.
ABSTRACT | FULL TEXT  

Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and {alpha}-cyclodextrin sulfate
Sugiuchi et al.
Clin. Chem. 1998;44:522-531.
ABSTRACT | FULL TEXT  

Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil
Mohan et al.
J. Lipid Res. 1998;39:255-267.
ABSTRACT | FULL TEXT  

Efficacy and Safety of a New Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitor, Atorvastatin, in Patients with Combined Hyperlipidemia: Comparison with Fenofibrate
Ooi et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1793-1799.
ABSTRACT | FULL TEXT  

Comparison of two assays for measuring LDL cholesterol
Maitra et al.
Clin. Chem. 1997;43:1040-1047.
ABSTRACT | FULL TEXT  

Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol
Huang et al.
Clin. Chem. 1997;43:1048-1055.
ABSTRACT | FULL TEXT  

Treatment of Hypothyroidism with Once Weekly Thyroxine
Grebe et al.
J. Clin. Endocrinol. Metab. 1997;82:870-875.
ABSTRACT | FULL TEXT  

Effects of Serum Lipoproteins and Smoking on Atherosclerosis in Young Men and Women
McGill et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:95-106.
ABSTRACT | FULL TEXT  

High-Density Lipoprotein Cholesterol and Risk of Ischemic Stroke Mortality: A 21-Year Follow-up of 8586 Men From the Israeli Ischemic Heart Disease Study
Tanne et al.
Stroke 1997;28:83-87.
ABSTRACT | FULL TEXT  

Low Total Serum Cholesterol and Intracerebral Hemorrhagic Stroke: Is the Association Confined to Elderly Men?: The Kaiser Permanente Medical Care Program
Iribarren et al.
Stroke 1996;27:1993-1998.
ABSTRACT | FULL TEXT  

Lipids and Stroke: A Paradox Resolved
Hachinski et al.
Arch Neurol 1996;53:303-308.
ABSTRACT  

Primary Prevention of Stroke
Bronner et al.
NEJM 1995;333:1392-1400.
FULL TEXT  

Dose-Response Relationships of Serum Lipid Measurements With the Extent of Coronary Stenosis : Strong, Independent, and Comprehensive
Bolibar et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1035-1042.
ABSTRACT | FULL TEXT  

Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study
Lindenstrom et al.
BMJ 1994;309:11-15.
ABSTRACT | FULL TEXT  

Hypercholesterolemia in Postmenopausal Women: Metabolic Defects and Response to Low-Dose Lovastatin
Arca et al.
JAMA 1994;271:453-459.
ABSTRACT  

Effect of a Single Oat Bran Cereal Breakfast on Serum Cholesterol, Lipoproteins, and Apolipoproteins in Patients With Hyperlipoproteinemia Type IIa
Bartram et al.
JPEN J Parenter Enteral Nutr 1992;16:533-537.
ABSTRACT  

The Prevalence of Cardiovascular Risk Factors Among Elderly Chinese Americans
Choi et al.
Arch Intern Med 1990;150:413-418.
ABSTRACT  

Hyperlipidemia Is a Risk Factor for Decreased Cerebral Perfusion and Stroke
Meyer et al.
Arch Neurol 1987;44:418-422.
ABSTRACT  

Differential Effects of Exercise on Serum Lipid and Lipoprotein Levels Seen With Changes in Body Weight: A Meta-analysis
Tran and Weltman
JAMA 1985;254:919-924.
ABSTRACT  

Choice and Use of Blood Lipid Tests: An Epidemiologic Perspective
Hulley and Lo
Arch Intern Med 1983;143:667-673.
ABSTRACT  

Diet and Hyperlipidemia: A Justifiable Debate
McNamara
Arch Intern Med 1982;142:1121-1124.
ABSTRACT